Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart Failure

This activity is supported by an educational grant from Novartis Pharmaceutical Corporation.

Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart Failure

Faculty

Carolyn Hempel, PharmD, BCPS

Clinical Assistant Professor

University at Buffalo School of Pharmacy

& Pharmaceutical Sciences

Clinical Pharmacist

Buffalo General Medical Center

Buffalo, New York

Tracy Macaulay, PharmD, BCPS (AQ Cardiology), AACC

Director, Transitional Care Pharmacy Services

University of Kentucky Healthcare

Director of Cardiovascular Pharmacy Services

Gill Heart Institute

Assistant Adjunct Professor

University of Kentucky

Lexington, Kentucky

Educational Objectives

After completing this continuing education program, the participant will be able to:

• Explain the clinical and economic burden of heart failure (HF).
• Examine the efficacy, safety, and potential role of emerging therapies for HF.
• Illustrate the overarching roles of health-system and community pharmacists as part of a multidisciplinary team for caring for patients with HF.
• Identify strategies that can help health-system and community pharmacists enhance transitions of care for patients with HF.

Target audience:

Pharmacists

Type of activity:

Application

Release date

: July 6, 2015

Expiration date:

July 6, 2017

Estimated time to complete activity:

2.0 hours

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-072-H01-P. The activity is available for CE credit through July 6, 2017.